- Home
- AMBQ vs ANGO Comparison
AMBQ vs ANGO Comparison
Compare AMBQ & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMBQ | ANGO |
|---|---|---|
| Founded | 2010 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 533.3M | 530.2M |
| IPO Year | 2025 | 2004 |
Fundamental Metrics
Financial Performance| Metric | AMBQ | ANGO |
|---|---|---|
| Price | $28.62 | $12.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | ★ $41.75 | $19.33 |
| AVG Volume (30 Days) | 89.8K | ★ 381.2K |
| Earning Date | 02-14-2026 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $72,109,000.00 | ★ $300,718,000.00 |
| Revenue This Year | N/A | $8.18 |
| Revenue Next Year | $22.30 | $5.15 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 10.03 | 2.73 |
| 52 Week Low | $22.12 | $8.27 |
| 52 Week High | $51.76 | $13.99 |
Technical Indicators
Market Signals| Indicator | AMBQ | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 47.73 |
| Support Level | N/A | $12.76 |
| Resistance Level | N/A | $13.91 |
| Average True Range (ATR) | 0.00 | 0.37 |
| MACD | 0.00 | -0.10 |
| Stochastic Oscillator | 0.00 | 7.83 |
Price Performance
Historical ComparisonAbout AMBQ Ambiq Micro Inc.
Ambiq Micro Inc is a fabless semiconductor company that has developed technology based on a patented Sub-threshold Power Optimized Technology (SPOT) platform that significantly reduces the amount of power consumed by integrated circuits. It is a pioneer and provider of ultra-low power semiconductor solutions designed to address the significant power consumption challenges of general purpose and AI compute - especially at the edge.
About ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.